Obese Patients With Nonalcoholic Fatty Liver Disease Have an Increase in Soluble Plasma CD163 and a Concurrent Decrease in Hepatic Expression of CD163

Obese Patients With Nonalcoholic Fatty Liver Disease Have an Increase in Soluble Plasma CD163 and a Concurrent Decrease in Hepatic Expression of CD163

Background and Aims: Macrophages play an important role in the development of nonalcoholic fatty liver disease (NAFLD) and its progression to nonalcoholic steatohepatitis (NASH). In this study, we investigated the hepatic expression of the macrophage scavenger receptor CD163 and the plasma level of...

Full description

Bibliographic Details
Main Authors: Maria Kløjgaard Skytthe, Felix Boel Pedersen, Charlotte Wilhelmina Wernberg, Vineesh Indira Chandran, Aleksander Krag, Tina Di Caterino, Samuel Coelho Mandacaru, Blagoy Blagoev, Mette Munk Lauridsen, Sönke Detlefsen, Jonas Heilskov Graversen, Søren Kragh Moestrup
Format: Article
Language:English
Published: Elsevier 2023-01-01
Series:Gastro Hep Advances
Subjects:
CD163
NASH
NAFLD
Immunohistochemistry
Proteomics
Translational
Online Access:http://www.sciencedirect.com/science/article/pii/S2772572323000419

Internet

http://www.sciencedirect.com/science/article/pii/S2772572323000419

Similar Items